Effective treatment of the tumors of the hematopoietic system now often depends on an exact prognosis for the disorder concerned, and so the hematopathologist can give vital direction to the hematologic or oncologic clinician. Prognostic Markers in Hematologic Oncology comprehensively presents the numerous predictive and prognostic parameters in the practice of oncologic haematology and underlines their clinical relevance.
IntroductionI. Overview of Predictive and Prognostic Markers in
Neoplastic Hematology. Phenotypic Markers. Chromosomal Markers II.
Predictive and Prognostic Markers in Specific Hematologic Disorders.
Peripheral (Mature) B-cell Lymphoproliferative Disorders. Peripheral (Mature
/ Post-Thymic) T-Cell Lymphoproliferative Disorders. Chronic Myeloid Leukemia
and other Chronic Myeloproliferative Disorders. Myelodysplastic Syndromes.
Acute Myeloid Leukemia. Precursos T- and B-Cell Neoplasms. Hodgkin Lymphoma
Genzyme Genetics, New York, USA
